Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana.

Journal of acquired immune deficiency syndromes (1999) - 15 Aug 2013

Souda Sajini, Gaseitsiwe Simani, Georgette Nathan, Powis Kathleen, Moremedi Daisy, Iketleng Thato, Leidner Jean, Moffat Claire, Ogwu Anthony, Lockman Shahin, Moyo Sikhulile, Mmalane Mompati, Musonda Rosemary, Makhema Joseph, Essex Max, Shapiro Roger

Abstract excerpt

Risk of developing drug resistance after stopping antiretroviral regimens to prevent mother-to-child HIV-1 transmission is unknown. The Mma Bana Study randomized treatment-naive pregnant women with CD4 ≥200 cells per cubic millimeter to receive either abacavir/zidovudine/lamivudine [triple nucleoside reverse transcriptase inhibitor (NRTI) arm] or lopinavir/ritonavir/zidovudine/lamivudine [protease inhibitor (PI)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Botswana

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Infectious Disease Transmission, Vertical

Share to Mutation, Missense

Source

Open in PubMed Open full text

Identifiers

PMID: 23542639
DOI: 10.1097/QAI.0b013e31829308f8
PMCID: PMC3762949

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana.PMID 23542639Read ↗

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana.Semantic proximity Read ↗

Low-frequency HIV-1 drug resistance mutations in antiretroviral naïve individuals in Botswana.Semantic proximity Read ↗

Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission.Semantic proximity Read ↗

Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.Semantic proximity Read ↗

Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana.Semantic proximity Read ↗

Drug resistance mutations 18 months after discontinuation of nevirapine-based ART for prevention of mother-to-child transmission of HIV in Malawi.Semantic proximity Read ↗

HIV-1 Subtype C Reverse Transcriptase Sequences from Drug-Naive Pregnant Women in South AfricaSemantic proximity Read ↗

Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa.Semantic proximity Read ↗

Virological Response and Drug Resistance 1 and 2 Years Post-Partum in HIV-Infected Women Initiated on Life-Long Antiretroviral Therapy in Malawi.Semantic proximity Read ↗

Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey.Semantic proximity Read ↗

A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.Semantic proximity Read ↗

Reverse transcriptase genotypes in pediatric patients failing initial antiretroviral therapy in Gaborone, Botswana.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.